MMP9 and diabetes mellitus: When compared to CHD subjects without diabetes, inflammatory markers (hsCRP, MMP-9) gradually increased in smokers with diabetes (“p-value” 0.0001), indicating that smokers with CHD who have a complication of diabetes significantly increase the systemic inflammation.